Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,669-1,680 of 1,745
Drug study icon
CompletedNCT01972711

Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In United Kingdom
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00257972

Aripiprazole in people with Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
BipolarityDrugOver 18 Years
Countries
United States, Australia, France, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT01716975

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Biological study icon
CompletedNCT02449746

Immunotherapy in Autoantibody Positive Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
SchizophreniaBiologicalFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
University of Cambridge
Condition
Schizophrenia
Drug study icon
CompletedNCT02731612

the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United Kingdom
BipolarityDrugFrom 19 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Lakshmi N Yatham
Condition
Bipolarity
Drug study icon
CompletedNCT03187769

Efficacy of ALKS 3831 on Body Weight for schizophrenia

This study is completed in the United States, in the United Kingdom, in Austria, .... It is testing Efficacy of ALKS 3831 on Body Weight for schizophrenia.

In United Kingdom
Bipolarity, SchizophreniaDrugFrom 16 Years to 40 Years
Countries
United States, United Kingdom, Austria, ...
Sponsor
Alkermes, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT05870501

Synaptic Imaging and Network Activity in Treatment Resistant Depression

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

In United Kingdom
Depression, BipolarityDrugFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.